Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Therapy for Cerebral Palsy
NCT03078621Phase 2Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Sep 2016
- Primary completion
- Oct 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous bone marrow-derived stem cells + mesenchymal stem cells in cerebral palsy (CP), sponsored by Stem Cells Arabia. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cells + mesenchymal stem cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03078621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078621.